[SGMO] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -125.84%
YoY- -108.80%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 28,231 26,280 13,076 8,071 12,637 3,425 3,942 38.81%
PBT -43,919 -45,677 -42,974 -42,203 -20,187 -16,632 -16,494 17.72%
Tax 58 262 -61 -53 -588 0 -245 -
NP -43,977 -45,933 -42,913 -42,150 -20,187 -16,632 -16,494 17.74%
Tax Rate - - - - - - - -
Total Cost 72,208 72,213 55,989 50,221 32,824 20,057 20,436 23.40%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -155.78 -174.78 -328.18 -522.24 -159.75 -485.61 -418.42 -15.17%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.30 -0.32 -0.37 -0.41 -0.23 -0.23 -0.23 4.52%
EPS Diluted -0.30 -0.32 -0.37 -0.41 -0.23 -0.23 -0.23 4.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.